Latest Episodes
Precision oncology: An overview of tumour agnostic therapies
What are tumour agnostic cancer treatments and which biomarkers do they target? Join Prof. David Hong (Medical Oncologist at MD Anderson Cancer Center, Houston,...
Prostate Cancer: Pre-Analytical Phase Challenges and Biomarker Testing
What are the common pre-analytical phase challenges in prostate cancer, and how can we overcome them? Why is it important to identify genetic alterations?...
Severe PHH. Part 2 - Learnings from clinical practice
In this podcast, Prof. Andra H. James (Professor Emeritus of Obstetrics and Gynecology, Division Maternal Fetal Medicine, Duke University Hospital, Durham, North Carolina, US)...
Managing thrombosis: Part 2 - Cancer and thrombosis
In this podcast episode, Prof Dimitrios Tsakiris (Haematologist, Basel University, Switzerland) and Dr Lars Asmis (Haematologist, University of Zurich, Switzerland) discuss the association between...
Advanced HCC: 2nd line treatment and the right time to switch
Prof. Dr Amit Singal, Gastroenterologist and Hepatologist at UT Southwestern Medical Center, USA and Prof. Dr Jeroen Dekervel, GI Oncologist at UZ Leuven, Belgium,...
Breast cancer: Oral SERDs in ER+ BC. Part 3 - Rare cases & treatment challenges
In this final episode, the experts discuss two patient case studies with oral SERDs (oral selective estrogen receptor degraders) and a novel therapy for...